350 related articles for article (PubMed ID: 28260142)
21. Acute phase clinical manifestations of patients with Vogt-Koyanagi-Harada disease in Southern China.
Zhang C; Wang Y; Chen Y; Zhou H; Hong Q; Yu X; Ng TK; Cen LP
BMC Ophthalmol; 2023 May; 23(1):199. PubMed ID: 37147563
[TBL] [Abstract][Full Text] [Related]
22. Vogt-Koyanagi-Harada Syndrome in a Group of Patients in Two Ophthalmology Referral Centers in Bogotá, Colombia.
Guayacán CL; Galindo-Mendez B; de-la-Torre A
Ocul Immunol Inflamm; 2018; 26(7):1123-1127. PubMed ID: 28910557
[TBL] [Abstract][Full Text] [Related]
23. Vogt-Koyanagi-Harada disease presenting as acute angle closure glaucoma at onset.
Yang P; Liu X; Zhou H; Guo W; Zhou C; Kijlstra A
Clin Exp Ophthalmol; 2011; 39(7):639-47. PubMed ID: 22452682
[TBL] [Abstract][Full Text] [Related]
24. [Clinical features, risk factors and progresses on treatment of recurrent Vogt-Koyanagi-Harada disease].
Jia SS; Zhao C; Liu XS; Zhang MF
Zhonghua Yan Ke Za Zhi; 2017 Apr; 53(4):317-320. PubMed ID: 28412807
[TBL] [Abstract][Full Text] [Related]
25. Clinical Outcomes of Patients with Vogt-Koyanagi-Harada Disease Over 12 Years at a Tertiary Center.
Arevalo JF; Lasave AF; Gupta V; Kozak I; Al Harbi MB; Al Rushood AA; Al Dhibi HA
Ocul Immunol Inflamm; 2016 Oct; 24(5):521-9. PubMed ID: 26399962
[TBL] [Abstract][Full Text] [Related]
26. The spectrum of Vogt-Koyanagi-Harada disease in South India.
Murthy SI; Moreker MR; Sangwan VS; Khanna RC; Tejwani S
Int Ophthalmol; 2007; 27(2-3):131-6. PubMed ID: 17318321
[TBL] [Abstract][Full Text] [Related]
27. Vogt-Koyanagi-Harada disease.
Damico FM; Kiss S; Young LH
Semin Ophthalmol; 2005; 20(3):183-90. PubMed ID: 16282153
[TBL] [Abstract][Full Text] [Related]
28. Management of ocular complications of Vogt-Koyanagi-Harada syndrome.
Perente I; Utine CA; Cakir H; Kaya V; Tutkun IT; Yilmaz OF
Int Ophthalmol; 2009 Feb; 29(1):33-7. PubMed ID: 17952373
[TBL] [Abstract][Full Text] [Related]
29. Chronic Recurrent Vogt-Koyanagi-Harada Disease and Development of 'Sunset Glow Fundus' Predict Worse Retinal Sensitivity.
Abu El-Asrar AM; Al Mudhaiyan T; Al Najashi AA; Hemachandran S; Hariz R; Mousa A; Al-Muammar A
Ocul Immunol Inflamm; 2017 Aug; 25(4):475-485. PubMed ID: 27003480
[TBL] [Abstract][Full Text] [Related]
30. Vogt-Koyanagi-Harada Syndrome in a Canadian First Nations Population.
Kryshtalskyj MT; Roy M
Ocul Immunol Inflamm; 2022 May; 30(4):894-900. PubMed ID: 33621146
[TBL] [Abstract][Full Text] [Related]
31. Sunset glow fundus in Vogt-Koyanagi-Harada disease with or without chronic ocular inflammation.
Keino H; Goto H; Usui M
Graefes Arch Clin Exp Ophthalmol; 2002 Oct; 240(10):878-82. PubMed ID: 12397437
[TBL] [Abstract][Full Text] [Related]
32. Band-shaped keratopathy in Chinese patients with Vogt-Koyanagi-Harada syndrome.
Yang P; Sun M
Cornea; 2011 Dec; 30(12):1336-40. PubMed ID: 21934492
[TBL] [Abstract][Full Text] [Related]
33. Diagnosis and classification of Vogt-Koyanagi-Harada disease.
Sakata VM; da Silva FT; Hirata CE; de Carvalho JF; Yamamoto JH
Autoimmun Rev; 2014; 13(4-5):550-5. PubMed ID: 24440284
[TBL] [Abstract][Full Text] [Related]
34. Relationship between retinal lesions and inward choroidal bulging in Vogt-Koyanagi-Harada disease.
Hosoda Y; Uji A; Hangai M; Morooka S; Nishijima K; Yoshimura N
Am J Ophthalmol; 2014 May; 157(5):1056-63. PubMed ID: 24491415
[TBL] [Abstract][Full Text] [Related]
35. Annular choroidal detachment in a patient with Vogt-Koyanagi-Harada disease.
Yamamoto N; Naito K
Graefes Arch Clin Exp Ophthalmol; 2004 Apr; 242(4):355-8. PubMed ID: 14963715
[TBL] [Abstract][Full Text] [Related]
36. Vogt-Koyanagi-Harada disease in Spain.
Arriola-Villalobos P; Moll-Udina A; Carrasco-López-Brea M; Sacristan C; Capella MJ; Peiteado D; Garrote-Llordén A; Albert Fort M; Jódar Márquez M; Jacobo Gonzalez Guijarro J; Demetrio-Pablo R; Luis Sánchez Sevilla J; Carreño E; González-López J; Miguel-Escuder L; Cuadros C; Díaz-Valle D; Adan A; ; Benítez Del Castillo JM; Fonollosa A; Cordero M; Martínez Costa L; Blanco-Alonso R
Eur J Ophthalmol; 2022 May; 32(3):1547-1554. PubMed ID: 34269103
[TBL] [Abstract][Full Text] [Related]
37. Prevalence, clinical characteristics, and causes of vision loss in children with Vogt-Koyanagi-Harada disease in South India.
Martin TD; Rathinam SR; Cunningham ET
Retina; 2010; 30(7):1113-21. PubMed ID: 20168275
[TBL] [Abstract][Full Text] [Related]
38. Analysis of 87 cases with Vogt-Koyanagi-Harada disease.
Mondkar SV; Biswas J; Ganesh SK
Jpn J Ophthalmol; 2000; 44(3):296-301. PubMed ID: 10913650
[TBL] [Abstract][Full Text] [Related]
39. Vogt-Koyanagi-Harada Disease Managed With Immunomodulatory Therapy Within 3 Months of Disease Onset.
Ei Ei Lin Oo ; Chee SP; Wong KKY; Hla Myint Htoon
Am J Ophthalmol; 2020 Dec; 220():37-44. PubMed ID: 32738228
[TBL] [Abstract][Full Text] [Related]
40. Vogt-Koyanagi-Harada disease in Thailand.
Yodmuang T; Rothova A; Kunavisarut P; Pathanapitoon K
Ocul Immunol Inflamm; 2012 Dec; 20(6):419-22. PubMed ID: 23163754
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]